The Misuse of Drugs (Amendment No. 2) Regulations (Northern Ireland) 2015

Type Ni-Statutory-Rule
Publication 2015-04-22
State In force
Jurisdiction Northern Ireland
Department Government Printer for Northern Ireland
PDF Download
articles Not indexed
Reform history JSON API

Made: 22nd April 2015

Coming into operation: 13th May 2015

The Department of Health, Social Services and Public Safety makes the following Regulations in exercise of the powers conferred by sections 7, 10, 22 and 31 of the Misuse of Drugs Act 1971 [^f00001] as adapted by sections 7(9), 31(4) and 38 of that Act and now vested in it [^f00002] and after consultation with the Advisory Council on the Misuse of Drugs in accordance with section 31(3) of that Act.

Citation, commencement and interpretation

1

Amendments to the Misuse of Drugs Regulations (Northern Ireland) 2002

2

The Misuse of Drugs Regulations (Northern Ireland) 2002 [^f00004] are amended as follows.

3

In paragraph 1(a) of Schedule 1 (which specifies controlled drugs subject to the requirements of regulations 14, 15, 16, 18, 19, 20, 23, 26 and 27)—

1-Cyclohexyl-4-(1,2-diphenylethyl)piperazine (MT-45)

4-Methyl-5-(4-methylphenyl)-4, 5-dihydrooxazol-2-amine (4,4’-DMAR)

Signed

Sealed with the Official Seal of the Department of Health, Social Services and Public Safety on 22nd April 2015.

Dr Anne Kilgallen — A senior officer of the — Department of Health, Social Services and Public Safety

Explanatory note

(This note is not part of the Regulations)

EXPLANATORY NOTE

These Regulations amend the Misuse of Drugs Regulations (Northern Ireland) 2002, “the 2002 Regulations”. The Schedule to the 2002 Regulations in which a controlled drug is placed primarily affects the extent to which the drug can be lawfully imported, exported, produced, supplied or possessed and dictates the record keeping, labelling and destruction requirements in relation to that drug. The controlled drugs placed in Schedule 1 to the 2002 Regulations are those subject to the tightest controls.

Regulation 3 adds a potent opioid known as MT-45 and a synthetic stimulant known as 4,4’-DMAR to Schedule 1 to the Regulations.

Footnotes

[^f00001]: 1971 c.38 as amended by s.151 of, and Schedule 17 to, the Police Reform and Social Responsibility Act 2011 c.13.

[^f00002]: S.R.& O. (N.I.) 1973 No.504, Article 5(a) and S.I.1999/283 (N.I.1), Article 3(6).

[^f00003]: 1954 c.33 (N.I.)

[^f00004]: S.R.2002 No.1. Relevant amending Regulations are S.R. 2015 No.53, S.R. 2014 No. 261, 158 and 21, S.R. 2013 Nos.78, S.R. 2012 No.213, S.R.2011 No.153, S.R.2010 Nos. 247 and 148 , S.R.2009 No.390, S.R.2007 No.348 and S.R.2005 No.360

Reading this document does not replace reading the official text published on legislation.gov.uk. Contains public sector information licensed under the Open Government Licence v3.0. We assume no responsibility for any inaccuracies arising from the conversion of the original CLML XML to this format.

This text is published under legislation.gov.uk's own terms of reuse, not a Legalize or public-domain licence. legislation.gov.uk
Open Government Licence v3.0 (attribution required)
© Crown and database right. Derived from content available under the Open Government Licence v3.0 from legislation.gov.uk.